Cowen initiated coverage on shares of Randsburg International Gold (OTCMKTS:CRLBF) in a research note released on Friday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $14.00 price objective on the stock.

A number of other analysts have also weighed in on the stock. Piper Jaffray Companies began coverage on shares of Randsburg International Gold in a research report on Monday, August 12th. They issued an overweight rating and a $11.00 target price on the stock. Compass Point began coverage on shares of Randsburg International Gold in a research report on Monday, June 10th. They issued a buy rating on the stock.

OTCMKTS CRLBF opened at $7.14 on Friday. The stock’s 50 day moving average price is $8.25. Randsburg International Gold has a 1 year low of $4.19 and a 1 year high of $14.39.

Randsburg International Gold Company Profile

Cresco Labs Inc manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products. The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews.

Recommended Story: Technical Analysis of Stocks and What It Means

Receive News & Ratings for Randsburg International Gold Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Randsburg International Gold and related companies with MarketBeat.com's FREE daily email newsletter.